Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Hopkinson Craig C. has filed 3 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jul 1, 2026.
Companies traded
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.1M
reported sales (SEC code S)
Companies
1
in the rolling window